XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN MEMBER’S AND SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Units
Common Stock
Member's Capital
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Foreign Currency Adjustment Attributable to Parent
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Ending balance (in shares)       0            
Ending balance       $ 0            
Beginning balance (in shares) at Dec. 31, 2020     108,724,422              
Beginning balance at Dec. 31, 2020 $ 474,488   $ 0   $ 571,038 $ 0 $ (96,550)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Effect of reorganization transaction (in shares)     (108,724,422) 108,724,387            
Effect of reorganization transaction 0     $ 11 (571,038) 571,027        
Issuance of common shares in IPO, net of issuance costs (in shares)       8,823,529            
Issuance of common shares in IPO, net of issuance costs 142,275     $ 1   142,274        
Stock-based compensation 81,112         81,112        
Net loss (91,767)           (91,767)      
Foreign currency translation adjustments (86)                 $ (86)
Change in cash flow hedge 0                  
Amortization of dedesignated cash flow hedge 0                  
Ending balance (in shares) at Dec. 31, 2021     0              
Ending balance at Dec. 31, 2021 606,022   $ 0   0 794,413 (188,317)   (86)  
Ending balance (Accounting Standards Update 2016-02) at Dec. 31, 2021   $ (18)           $ (18)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Ending balance (in shares)       117,547,916            
Ending balance       $ 12            
Stock-based compensation 87,697         87,697        
Issuance of common stock under stock plan (in shares)       5,082,024            
Shares withheld related to net share settlement       (5,526)            
Shares withheld related to net share settlement (41)         (41)        
Net loss (382,140)           (382,140)      
Foreign currency translation adjustments (61)                 (61)
Change in cash flow hedge 23,410                 23,410
Amortization of dedesignated cash flow hedge 0                  
Ending balance (in shares) at Dec. 31, 2022     0              
Ending balance at Dec. 31, 2022 334,869   $ 0   0 882,069 (570,475)   23,263  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Ending balance (in shares)       122,624,414            
Ending balance 334,869     $ 12            
Issuance of common shares in IPO, net of issuance costs 1     $ 1            
Stock-based compensation 53,203         53,203        
Issuance of common stock under stock plan (in shares)       3,240,889            
Net loss (84,402)           (84,402)      
Foreign currency translation adjustments 129                 129
Change in cash flow hedge (2,088)                 (2,088)
Amortization of dedesignated cash flow hedge (10,364)                 $ (10,364)
Ending balance (in shares) at Dec. 31, 2023     0              
Ending balance at Dec. 31, 2023 291,348   $ 0   $ 0 $ 935,272 $ (654,877)   $ 10,940  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Ending balance (in shares)       125,865,303            
Ending balance $ 291,348     $ 13